SOST and type 2 diabetes mellitus: For immunohistochemistry, the analysis of the total average of sclerostin-positive cells revealed a significantly higher expression of sclerostin in T2D patients’ vessels compared to control subjects’ vessels (96.18 ± 13.61 vs. 17.25 ± 2.18, p = 0.003).